tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNAC Stock Latest News

Strategic Pivot and Promising Clinical Data Justify Buy Rating for Cartesian Therapeutics
RatingsStrategic Pivot and Promising Clinical Data Justify Buy Rating for Cartesian Therapeutics
11d ago
RNAC
H.C. Wainwright cuts Cartesian target, calls shares ‘mispriced’
PremiumThe Fly
H.C. Wainwright cuts Cartesian target, calls shares ‘mispriced’
14d ago
RNAC
Strategic Realignment Boosts Cartesian Therapeutics’ Prospects: Gil Blum Issues Buy Rating
PremiumRatings
Strategic Realignment Boosts Cartesian Therapeutics’ Prospects: Gil Blum Issues Buy Rating
18d ago
RNAC
Cartesian Therapeutics price target raised to $44 from $42 at BTIG
PremiumThe Fly
Cartesian Therapeutics price target raised to $44 from $42 at BTIG
19d ago
RNAC
Cartesian Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
Cartesian Therapeutics Reports Q3 2025 Financial Results
19d ago
RNAC
Cartesian announces positive initial data from Phase 2 SLE trial of Descartes-08
PremiumThe FlyCartesian announces positive initial data from Phase 2 SLE trial of Descartes-08
19d ago
RNAC
Cartesian Therapeutics Reports Promising Phase 2 Trial Results
Premium
Company Announcements
Cartesian Therapeutics Reports Promising Phase 2 Trial Results
19d ago
8K
RNAC
Cartesian Therapeutics reports Q3 EPS ($1.38) vs ($1.13) last year
Premium
The Fly
Cartesian Therapeutics reports Q3 EPS ($1.38) vs ($1.13) last year
27d ago
RNAC
Cartesian Therapeutics Announces Leadership Changes
PremiumCompany Announcements
Cartesian Therapeutics Announces Leadership Changes
1M ago
8K
RNAC
Cartesian Therapeutics announces employment inducement grant
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grant
1M ago
RNAC
Cartesian Therapeutics appoints Brunn as Chairman of Board
PremiumThe Fly
Cartesian Therapeutics appoints Brunn as Chairman of Board
1M ago
RNAC
Cartesian Therapeutics’ Descartes-08: A Promising Phase 3 Trial for Myasthenia Gravis
PremiumCompany Announcements
Cartesian Therapeutics’ Descartes-08: A Promising Phase 3 Trial for Myasthenia Gravis
1M ago
RNAC
Cartesian Therapeutics Advances Autoimmune Disorder Treatment with Descartes-08 Study
PremiumCompany AnnouncementsCartesian Therapeutics Advances Autoimmune Disorder Treatment with Descartes-08 Study
1M ago
RNAC
Cartesian Therapeutics Advances SLE Treatment with Descartes-08 Study
Premium
Company Announcements
Cartesian Therapeutics Advances SLE Treatment with Descartes-08 Study
1M ago
RNAC
Cartesian Therapeutics Eliminates Chief Scientific Officer Role
Premium
Company Announcements
Cartesian Therapeutics Eliminates Chief Scientific Officer Role
1M ago
8K
RNAC
Cartesian Therapeutics Appoints New Chief Accounting Officer
PremiumCompany Announcements
Cartesian Therapeutics Appoints New Chief Accounting Officer
2M ago
8K
RNAC
Cartesian Therapeutics announces employment inducement grant
PremiumThe Fly
Cartesian Therapeutics announces employment inducement grant
2M ago
RNAC
Promising Potential of Cartesian Therapeutics: Buy Rating Backed by Phase III AURORA Trial and Descartes-08 Performance
PremiumRatings
Promising Potential of Cartesian Therapeutics: Buy Rating Backed by Phase III AURORA Trial and Descartes-08 Performance
4M ago
RNAC
Promising Developments and Strong Financial Health Support Buy Rating for Cartesian Therapeutics
PremiumRatings
Promising Developments and Strong Financial Health Support Buy Rating for Cartesian Therapeutics
4M ago
RNAC
Cartesian Therapeutics Reports Positive Q2 2025 Earnings
PremiumCompany AnnouncementsCartesian Therapeutics Reports Positive Q2 2025 Earnings
4M ago
RNAC
Optimistic Buy Rating for Cartesian Therapeutics Driven by Promising Clinical Pipeline and Strong Financial Health
Premium
Ratings
Optimistic Buy Rating for Cartesian Therapeutics Driven by Promising Clinical Pipeline and Strong Financial Health
4M ago
RNAC
Cartesian Therapeutics reports Q2 EPS 50c vs. 54c last year
Premium
The Fly
Cartesian Therapeutics reports Q2 EPS 50c vs. 54c last year
4M ago
RNAC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >